Vericel on Track for Robust Second Half in 2021

By Mike Evers

Vericel on Track for Robust Second Half in 2021
The company outperformed expectations so far for 2021 and remains on track to realize growth in the 30% range for the full year.

Member-Only Content

SUBSCRIBE Login

Product Labels: PRP/Cell-Based/Osteoinductive Materials

Tags: Revenue Report